NCT05161611View on ClinicalTrials.gov

Effect of Oral Zinc Sulfate on Jaundice in Neonates Admitted to Neonatal Intensive Care Unit

NACompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

December 17, 2021

Primary Completion Date

August 28, 2022

Study Completion Date

August 28, 2022

Conditions
Serum Bilirubin
Interventions
DRUG

Zinc sulfate

10 mg of oral zinc sulfate will be given to neonates per day

OTHER

Placebo

10 mg of normal saline will be given to neonates per day

OTHER

Phototherapy

Neonates will be put under phototherapy

Trial Locations (1)

Unknown

Makassed General Hospital, Beirut

All Listed Sponsors
lead

Makassed General Hospital

OTHER

NCT05161611 - Effect of Oral Zinc Sulfate on Jaundice in Neonates Admitted to Neonatal Intensive Care Unit | Biotech Hunter | Biotech Hunter